Company Details

  • Shandong Chenyi Environmental Protection Technology Co.,Ltd

  •  [Shandong,China]
  • Business Type:Manufacturer
  • Main Mark: Worldwide
  • Exporter:91% - 100%
  • Certs:ISO9001, API, ISO9002
Inquiry Basket ( 0 )

Shandong Chenyi Environmental Protection Technology Co.,Ltd

Home > News > Xinhua double Jie: the backbone of Zibo's industrial rise

Xinhua double Jie: the backbone of Zibo's industrial rise

Talking about the pharmaceutical industry in Shandong, we can not get around the largest pharmaceutical industry base in Zibo.

In Zibo Pharmaceutical Industry, Xinhua Pharmaceutical and Xinhua Medical, known as "Xinhua Shuangjie", are the two enterprises that can best represent the development level of the local pharmaceutical industry.

Of particular concern is that at the important time of the 40th anniversary of reform and opening up, "Xinhua Shuangjie" ushered in its 75th birthday. The emergence of dual significance has made the industry pay special attention to these two enterprises.

In fact, it is not difficult to find that the innovative development of the two enterprises is also a true epitome of the upgrading of Zibo's traditional industries and the rising of strategic emerging industries since the reform and opening up.

Now, standing at a new starting point of development, "Xinhua Shuangjie" ushered in a broader space, which also made Zibo industry revival and rise with more support.

From raw materials to large pharmaceutical industry chain is constantly improving

In November 1st, it was a memorable day for Xinhua pharmaceuticals. On the same day, the modern international pharmaceutical Cooperation Center project was officially launched. This project is a key investment project for the conversion of new and old kinetic energy in Shandong Province, with a total investment of 800 million yuan and an annual production capacity of 20 billion pieces in accordance with the advanced international GMP standards.

After the project is launched, it will greatly promote the pace of new and old kinetic energy conversion and industrial upgrading of Xinhua Pharmaceutical Co., Ltd., and become a new starting point for leapfrog development.

From the large exporters of API to the large producers of tablets, the industrial chain of Xinhua medicine has been continuously improved. In recent years, Xinhua Pharmaceutical has carried out the strategy of "big preparations" with frequent actions, focusing on strengthening and enlarging preparations, continuing to consolidate and stabilize the development of APIs, and focusing on the adjustment of raw materials and preparations from the perspective of APIs.

The so-called "big preparation strategy" is to strengthen and expand preparations, develop products with high added value, and even products with independent intellectual property rights, focus on large varieties, expand and strengthen several pharmaceutical products with over 100 million sales, and completely change the situation in which the proportion of raw material drugs is larger. In 2017, another product of Xinhua pharmaceuticals was sold over 100 million.

Xinhua Pharmaceutical has a state-level enterprise technology center, which has core technical advantages in new product imitation, development, new dosage forms and new preparation development of chemical raw materials. In recent years, we have successfully developed the national class I new drug Aidit, the national class II new drug Anka, Jiahe Luo, Shutaide, and 3.1 new drug Baochang, four new drugs Jiening and other products.

Nowadays, Xinhua Pharmaceutical has six major parks, covering more than 4000 mu. Headquarters Park, First Factory, Second Factory, High-density Park, Shouguang Park and future API production base constitute a comprehensive pharmaceutical enterprise with Pharmaceutical Intermediates, APIs and high-end preparations.

The development of the whole industry chain has brought new vitality to Xinhua Pharmaceutical. In 2017, Xinhua Pharmaceutical realized business income of nearly 5 billion yuan, an increase of 12.4% over the same period last year, and profit of 274 million yuan, an increase of 68.6% over the same period last year.

Improving the industrial chain is also an important action of Xinhua healthcare. Xinhua Medical has developed into a leading Chinese medical device enterprise in three business sectors: medical devices and equipment, pharmaceutical equipment and medical services. It is learnt that the future. Xinhua Medical will continue to strengthen the health industry, develop health energy and serve healthy Shandong, build a special hospital management structure with Xinhua medical characteristics, and gradually realize the transformation from medical device manufacturers to service providers.

Share to:  
Communicate with Supplier?Supplier
What can I do for you?
Contact Supplier